Martin Offringa

SickKids-led papers co-published in BMJ, JAMA and Lancet journals introduce 30 new protocols and reporting items for paediatric randomized controlled trials, co-developed with youth and family caregivers. Read the #SKResearch ⬇️ sickkids.ca/en/news/archiv…

📄 This JAMA Pediatrics Patient Page describes how new guidance aiming to improve reporting of clinical trials may help young people and parents find information to make the right health care decisions for them. ja.ma/3Oxvy2c

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years. ja.ma/3OAOPjg

The CONSORT–Children and Adolescents (CONSORT-C) 2026 guideline extends CONSORT 2025 with 13 new reporting items for pediatric RCTs, enhancing transparency, reproducibility, and relevance for patients aged 0 to 19 years. ja.ma/4ax2T67

💬 Editor's Note from JAMA Pediatrics Editor in Chief Dimitri A. Christakis, MD, MPH: The new CONSORT-C and SPIRIT-C guidelines mark a pivotal advance in pediatric research by establishing standards that reflect the unique needs of children. ja.ma/4c3ehHY

Guidelines set new playbook for paediatric clinical trials sickkids.ca/en/news/archiv…

📢 New paper alert! The TIDieR-C guideline presents 13 pediatric considerations to support transparent reporting of trial interventions in pediatric trial protocols & reports. Paper ➡️ tinyurl.com/ymbves7p Fillable checklists ➡️ tinyurl.com/56nfj25p

Science is not a contest to be won. It’s a collective pursuit of truth that evolves with evidence - not a debate settled by opinion or the loudest voice.

Late systemic administration of dexam. is considered an effective intervention to reduce the risk of BPD in infants with a high risk profile for BPD. Endotracheal instillation of budesonide with surfactant as a carrier is a promising intervention. doi.org/10.1002/146518…

2024 revision to the Declaration of Helsinki @JAMA_current highlights the importance of completeness & accuracy of study reports + adhere to accepted guidelines for reporting jamanetwork.com/journals/jama/… Visit our guideline repository at the EQUATOR Network equator-network.org

📢 Attention Clinical Trialists: We are hiring a post-doc fellow with expertise in rare disease/child health clinical trial methods for RareKids-CAN: a new Canadian Pediatric Rare Disease Clinical Trials and Treatment Network! ➡️ For more info & to apply: tinyurl.com/pfh9n9t8

A few weeks ago the @WHO published new guidance on best practice for clinical trials. It provides really useful considerations for the design and delivery of a quality trial & the wider trials eco-system 1/6 #MethodologyMonday #101

TLDR: if you haven’t read the new #WHO guidance on best practices for clinical trials yet, you should!! Link here … 6/6 iris.who.int/bitstream/hand…

Today is #WorldMentalHealthDay 💙 This year's theme is 'It is Time to Prioritise Mental Health in the Workplace'. On this World Mental Health Day, let's prioritize our mental well-being. For more information check out the website linked below. Link: (wmhdofficial.com)

@Maureenchats and @BethPotter4 sharing how they have been learning about how to include people with lived experience in the ‘how’ stage (COMS). Great meeting organised by @GorstSarah from COMET!

It's here! The @WHO guidance for best practices in clinical trials. Appreciate the "always on, always warm" trial infrastructure rec which will have game changing impact on our ability to answer clinical questions that matter more efficiently. Read 👇🏻 iris.who.int/bitstream/hand…

TWO NEW PAPERS in @bmj_latest on reporting recommendations for trials with surrogate outcomes (wonderfully led by @AnthonyManyara_ and @OrianaCiani) CONSORT: bmj.com/content/386/bm… SPIRIT: bmj.com/content/386/bm… #reporting #transparency #RCT

Hot off the press! The #PrismaCosmin reporting guideline is here! Find the reporting checklist and the full publication here: shorturl.at/EFCui. Find additional resources to help you use the #ReportingGuideline at prisma-cosmin.ca!

Major development in Clinical Trial Reporting, this week: